1597422-16-6Relevant articles and documents
A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate
Cheng, Janice M. H.,Dangerfield, Emma M.,Timmer, Mattie S. M.,Stocker, Bridget L.
supporting information, p. 2729 - 2736 (2014/05/06)
Isoglobotrihexosylceramide (iGb3, 1) is an immunomodulatory glycolipid that binds to CD1d and is presented to the T-cell receptor (TCR) of invariant natural killer T (iNKT) cells. To investigate how modifications to the lipid tail or terminal sugar residu